NCT00480857View on ClinicalTrials.gov

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2013

Study Completion Date

July 31, 2014

Conditions
Prostate Cancer
Interventions
DRUG

Docetaxel (Taxotere)

Concurrent weekly docetaxel at 20mg/m2 with radiation therapy. Chemo dose may be held or reduced based on specific lab parameters.

Trial Locations (1)

48109-5010

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER